Maria Gheorghe
Bucharest, B, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Broadening the Assessment of Antimicrobial Value: Insights from Two Evaluations of Aztreonam-Avibactam in Spain.
Journal: Infectious diseases and therapy
Published: March 25, 2026
Management of metallo-β-lactamase-producing Enterobacterales infections: a modified Delphi study.
Journal: JAC-antimicrobial resistance
Published: October 28, 2025
Cost-Effectiveness Analysis of Aztreonam-Avibactam Compared with Colistin Plus Meropenem in Treating Metallo-Beta-Lactamase-Producing Enterobacterales Infections in Spain.
Journal: Infectious diseases and therapy
Published: August 29, 2025
Estimating the Value of Aztreonam-Avibactam in Treating Metallo-beta-Lactamase-Producing Enterobacterales Infections in Spain Using the STEDI AMR Value Framework.
Journal: Infectious diseases and therapy
Published: May 20, 2025
Extended Analysis of the Hospitalization Cost and Economic Burden of COVID-19 in Romania.
Journal: Healthcare (Basel, Switzerland)
Published: March 14, 2025
Epidemiology and outcomes associated with MBL-producing Enterobacterales: A systematic literature review.
Journal: International journal of antimicrobial agents
Published: July 26, 2024
Antimicrobial resistance trends, predictors, and burden in England: a retrospective study using the Clinical Practice Research Datalink from 2015 to 2021.
Journal: International journal of antimicrobial agents
Published: March 27, 2024
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study.
Journal: PharmacoEconomics
Published: November 05, 2023
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom.
Journal: PharmacoEconomics
Published: July 23, 2023
Using Behavior Change Theory to Identify Drivers and Barriers for Antifungal Treatment Decisions: A Case Study in a Large Teaching Hospital in the East of England, UK.
Journal: Infectious diseases and therapy
Published: December 30, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026